Spatio-temporal localization of HIF-1α and COX-2 during irradiation-induced oral mucositis in a rat model system

References

• Albina J E, Mastrofrancesco B, Vessella J A, Louis C A, Henry W L, Reichner J S. HIF-1 expression in healing wounds: HIF-1alpha induction in primary inflammatory cells by TNF-alpha. American Journal of Physiology and Cellular Physiology 2001; 281: C1971–C1977
   PubMed Web of Science ®Google Scholar
• Beasley N JP, Leek R, Alam M, Turley H, Cox G J, Gatter K, Millard P, Fuggle S, Harris A L. Hypoxia-inducible factors HIF-1α and HIF-2α in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Research 2002; 62: 2493–2497
   PubMed Web of Science ®Google Scholar
• Bloomer W D, Hellman S. Normal tissue responses to radiation therapy. New England Journal of Medicine 1975; 293: 80–83
   PubMed Web of Science ®Google Scholar
• Brennan P A, Mackenzie N, Quintero M. Hypoxia-inducible factor 1α in oral cancer. Journal of Oral Pathology and Medicine 2005; 34: 385–389
   PubMed Web of Science ®Google Scholar
• Carey M A, Bradbury J A, Seubert J M, Langenbach R, Zeldin D C, Germolec D R. Contrasting effects of cyclooxygenase-1 (COX-1) and COX-2 deficiency on the host response to influenza A viral infection. Journal of Immunology 2005; 175: 6878–6884
   PubMed Web of Science ®Google Scholar
• Chan C ML, Ma B BY, Hui E P, Wong S CC, Mo F KF, Leung S F, Kam M KM, Chan A T. Cyclooxygenase-2 expression in advanced nasopharyngeal carcinoma – a prognostic evaluation and correlation with hypoxia inducible factor 1 alpha and vascular endothelial growth factor. Oral Oncology 2007; 43: 373–378
   PubMed Web of Science ®Google Scholar
• Fillies T, Werkmeister R, van Diest P J, Brandt B, Joos U, Buerger H. HIF-1α overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floor. BMC Cancer 2005; 5: 84–93
   PubMed Web of Science ®Google Scholar
• Giatromanolaki A, Harris A L. Tumour hypoxia, hypoxia signaling pathways and hypoxia inducible factor expression in human cancer. Anticancer Research 2001; 21: 4317–4324
   PubMed Web of Science ®Google Scholar
• Griffith E A, Pritchard S A, Welch I M, Price P M, West C M. Is the hypoxia-inducible factor pathway important in gastric cancer?. European Journal of Cancer 2005; 41: 2792–2805
   PubMed Web of Science ®Google Scholar
• Haddad J J, Land S C. A non-hypoxic, ROS-sensitive pathway mediates TNF-alpha-dependent regulation of HIF-1alpha. FEBS Letters 2001; 505: 269–274
   PubMed Web of Science ®Google Scholar
• Hellwig-Burgel T, Stiehl D P, Wagner A E, Metzen E, Jelkmann W. Hypoxia-inducible factor-1 (HIF-1): a novel transcription factor in immune reactions. Journal of Interferon and Cytokine Research 2005; 25: 297–310
   PubMed Web of Science ®Google Scholar
• Isa A Y, Ward T H, West C ML, Slevin N J, Homer J J. Hypoxia in head and neck cancer. British Journal of Radiology 2006; 79: 791–798
   PubMed Web of Science ®Google Scholar
• Jeong H J, Chung H S, Lee B R, Kim S J, Yoo S J, Hong S H, Kim H M. Expression of proinflammatory cytokines via HIF-1alpha and NF-kappaB activation on desferrioxamine-stimulated HMC-1 cells. Biochemical Biophysical Research Communications 2003; 306: 805–811
   PubMed Web of Science ®Google Scholar
• Jung Y J, Isaacs J S, Lee S, Trepel J, Neckers L. IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB Journal 2003; 17: 2115–2117
   PubMed Web of Science ®Google Scholar
• Koga H, Sakisaka S, Ohishi M, Kawaguchi T, Taniguchi E, Sasatomi K, Harada M, Kusaba T, Tanaka M, Kimura R, Nakashima Y, Nakashima O, Kojiro M, Kurohiji T, Sata M. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Hepatology 1999; 29: 688–696
   PubMed Web of Science ®Google Scholar
• Kurumbail R G, Stevens A M, Gierse J K, McDonald J J, Stegeman R A, Pak J Y, Gildehaus D, Miyashiro J M, Penning T D, Seibert K, Isakson P C, Stallings W C. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 1996; 384: 644–648
   PubMed Web of Science ®Google Scholar
• Logan R M, Gibson R J, Sonis S T, Keefe D MK. Nuclear factor-κB (NF-κB) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapy. Oral Oncology 2007; 43(4)395–401
   PubMed Web of Science ®Google Scholar
• Lukiw W J, Ottlecz A, Lambrou G, Grueninger M, Finley J, Thompson H W, Bazan N G. Coordinate activation of HIF-1 and NF-kappaB DNA binding and COX-2 and VEGF expression in retinal cells by hypoxia. Investigative Ophthalmology and Visual Sciences 2003; 44: 4163–4170
   PubMed Web of Science ®Google Scholar
• McNeill L A, Hewitson K S, Gleadle J M, Horsfall L E, Oldham N J, Maxwell P H, Pugh C W, Ratcliffe P J, Schofield C J. The use of dioxygen by HIF prolyl hydroxylase (PHD1). Bioorganic and Medicinal Chemistry Letters 2002; 12: 1547–1550
   PubMed Web of Science ®Google Scholar
• Metzen E, Zhou J, Jelkmann W, Fandrey J, Brune B. Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases. Molecular Biology of the Cell 2003; 14: 3470–3481
   PubMed Web of Science ®Google Scholar
• Quintero M, Mackenzie N, Brennan P A. Hypoxia-inducible factor 1 (HIF-1) in cancer. EJSO 2004; 30: 465–468
   PubMed Web of Science ®Google Scholar
• Semenza G L. Hypoxia-inducible factor 1: control of oxygen homeostasis in health and disease. Pediatrics Research 2001; 49: 614–617
   PubMed Web of Science ®Google Scholar
• Sonis S T. The biologic role for nuclear factor-kappaB in disease and its potential involvement in mucosal injury associated with anti-neoplastic therapy. Critical Reviews in Oral Biological Medicine 2002; 13: 380–389
   PubMedGoogle Scholar
• Sonis S T. The pathobiology of mucositis. Nature Reviews in Cancer 2004; 4: 277–284
   PubMed Web of Science ®Google Scholar
• Sonis S T, Elting L S, Keefe D, Peterson D E, Schubert M, Hauer-Jensen M, Bekele B N, Raber-Durlacher J, Donnelly J P, Rubenstein E B. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 2004a; 100: 1995–2025
   PubMed Web of Science ®Google Scholar
• Sonis S T, O'Donnell K E, Popat R, Bragdon C, PHelan S, Cocks D, Epstein J B. The relationship between mucosal cyclooxygenase-2 (COX-2) expression and experimental radiation-induced mucositis. Oral Oncology 2004b; 40: 170–176
   PubMed Web of Science ®Google Scholar
• Sonis S T, Peterson R L, Edwards L J, Lucey C A, Wang L, Mason L, Login G, Ymamkawa M, Moses G, Bouchard P, Hayes L L, Bedrosian C, Dorner A J. Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters. Oral Oncology 2000; 36: 373–381
   PubMed Web of Science ®Google Scholar
• Thornton R D, Lane P, Borghaei R C, Pease E A, Caro J, Mochan E. Interleukin 1 induces hypoxia-inducible factor 1 in human gingival and synovial fibroblasts. Biochemical Journal 2000; 350: 307–312
   PubMed Web of Science ®Google Scholar
• Trotti A, Bellm L A, Epstein J B, Frame D, Fuchs H J, Gwede C K, Komaroff E, Nalysnyk L, Zilberberg M D. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiotherapy and Oncology 2003; 66: 253–262
   PubMed Web of Science ®Google Scholar
• Xia R-H, Ao T-L, Yu J-Z, Jin X-R. HIF-1 and erythropoietin 3′-enhancer regulation the transcription of endothelial cyclooxygenase and TXS. Chinese Journal of Applied Physiology 2000; 16: 48–51
   Google Scholar
• Yeoh A SJ, Bowen J M, Gibson R J, Keefe D MK. Nuclear factor κB (NFκB) and cyclooxygenase-2 (Cox-2) expression in the irradiated colorectum is associated with subsequent histopathological changes. International Journal of Radiation, Oncology, and Biological Physics 2005; 63: 1295–1303
   PubMed Web of Science ®Google Scholar
• Yeoh A, Gibson R, Yeoh E, Bowen J, Stringer A, Giam K, Logan R, Keefe D. Radiation therapy-induced mucositis: relationships between fractionated radiation, NF-κB, COX-1, and COX-2. Cancer Treatment Reviews 2006; 32: 645–651
   PubMed Web of Science ®Google Scholar
• Zhang Q, Zhang Z-F, Rao J Y, Sato J D, Brown J, Messadi D V, Le A D. Treatment with siRNA and antisense oligonucleotides targeted to HIF-1α induced apoptosis in human tongue squamous cell carcinomas. International Journal of Cancer 2004; 111: 849–857
   PubMed Web of Science ®Google Scholar